Metabolic effects of aldosterone

Metabolic effects of aldosterone

Currently, increasing evidence shows the mutual influence of aldosterone and adipose tissue. Aldosterone excess has been reported in patients with obesity and metabolic syndrome. Aldosterone has a direct effect on adipose tissue increasing anabolic activity and expression of mineralocorticoid recept...

Full description

Bibliographic Details
Main Authors:	K. V. Ivashchenko, N. V. Mazurina, N. M. Platonova, E. A. Troshina
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2024-01-01
Series:	Ожирение и метаболизм
Subjects:	aldosterone obesity metabolic syndrome primary hyperaldosteronism glucose homeostasis fat tissue renin-angiotensin-aldosterone system
Online Access:	https://www.omet-endojournals.ru/jour/article/view/13040

Similar Items

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

The effect of medication on the aldosterone‐to‐renin ratio. A critical review of the literature
by: Rawan M. Alnazer, et al.
Published: (2021-02-01)

Confounders of the aldosterone‐to‐renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature
by: Gregory P. Veldhuizen, et al.
Published: (2021-02-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
by: E. A. Dobreva, et al.
Published: (2020-11-01)

Survey of renin and aldosterone testing practices by Ontario laboratories – Providing insight into best practices
by: Angela C. Rutledge, et al.
Published: (2021-05-01)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
by: Toshitaka Sawamura, et al.
Published: (2020-11-01)

Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age
by: Seung Hun Lee, et al.
Published: (2021-04-01)

Changes in plasma aldosterone level after weight loss by bariatric surgery in morbidly obese patients
by: Preaw Suwannasrisuk, et al.
Published: (2020-04-01)

Diagnosis and management of primary aldosteronism
by: Leticia A. P. Vilela, et al.

Who needs to be screened for primary aldosteronism?
by: Wei-Chieh Huang, et al.
Published: (2024-03-01)

Relationship of plasma aldosterone levels and carbohydrate metabolism in heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-02-01)

Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
by: Huai Heng Loh, et al.
Published: (2022-09-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs
by: Bongeka Cassandra Mkhize, et al.
Published: (2022-05-01)

Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trialResearch in context
by: Paolo Mulatero, et al.
Published: (2024-05-01)

Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism
by: Sumaiya Ahmed, et al.
Published: (2022-04-01)

Who should be screened for primary aldosteronism? A comprehensive review of current evidence
by: Wei‐Chieh Huang, et al.
Published: (2022-09-01)

The activity of the renin-angiotensin-aldosterone system before and after parathyroidectomy in patients with primary hyperparathyroidism
by: Liubov G. Yanevskaya, et al.
Published: (2021-12-01)

Aldosterone synthase gene polymorphism in alimentary obesity, metabolic syndrome components, some secondary forms of arterial hypertension, pathology of the adrenals glands core (literature review)
by: S.N. Koval, et al.
Published: (2017-08-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism
by: Marta Araujo-Castro, et al.
Published: (2024-03-01)

Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities
by: Adina F. Turcu, et al.
Published: (2022-07-01)

Poor Performance of Angiotensin II Enzyme-Linked Immuno-Sorbent Assays in Mostly Hypertensive Cohort Routinely Screened for Primary Aldosteronism
by: Agnieszka Łebek-Szatańska, et al.
Published: (2022-04-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone‐producing adenoma and idiopathic hyperaldosteronism
by: Mikiko Okazaki‐Hada, et al.
Published: (2020-11-01)

Prevalence of an angiotensin-converting enzyme gene variant in dogs
by: D. B. Adin, et al.
Published: (2021-07-01)

The role of the tissue renin-angiotensin-aldosterone system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

RAA System and Exercise Relationship
by: Sadettin Ünsal, et al.
Published: (2019-09-01)

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model
by: Seung-Hwa Lee, et al.
Published: (2022-01-01)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
by: Marisa K. Ames, et al.
Published: (2022-11-01)

Recent Development toward the Next Clinical Practice of Primary Aldosteronism: A Literature Review
by: Yuta Tezuka, et al.
Published: (2021-03-01)

Captopril challenge test: an underutilized test in the diagnosis of primary aldosteronism
by: Sharmin Jahan, et al.
Published: (2024-01-01)

Low plasma renin activity is associated with “Apparently” idiopathic atrial fibrillation
by: Youmei Shen, et al.
Published: (2023-12-01)